Birmingham, AL, United States of America

John Christopher Kappes

This inventor holds 8 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: The UAB Research Foundation (The University of Alabama at Birmingham), The University of Alabama, Texas Tech University System. Active years: 1999-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Christopher Kappes. Retrieved from https://idiyas.com/inventor/john-christopher-kappes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 62.5


Average Co-Inventor Count = 2.1

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Birmingham, AL (US) (1999 - 2009)
  • Homewood, AL (US) (2023)

Company Filing History:


Years Active: 1999-2023

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of John Christopher Kappes**

Introduction

John Christopher Kappes, an accomplished inventor based in Birmingham, Alabama, has made significant strides in the field of biotechnology. With a total of eight patents to his name, Kappes focuses on enhancing genetic therapies and improving the stability of critical proteins, showcasing his dedication to scientific advancement.

Latest Patents

Among his latest inventions is a patent for **Modified cystic fibrosis transmembrane conductance regulator (CFTR) polypeptides with increased stability and uses thereof**. This invention targets modified CFTR proteins or fragments, which incorporate amino acid mutations aimed at enhancing structural stability. Specifically, these modified proteins differ from the wild-type human CFTR protein by exhibiting four or more mutations that increase their stability compared to their wild-type counterparts. Another notable contribution is his patent for **Trans-lentiviral vector particles and transduction of eukaryotic cells therewith**. This invention details trans-lentiviral gene transfer vectors and methodologies for transducing primary nondividing cells, with enhancements aimed at improving transduction efficiency and gene expression.

Career Highlights

Kappes has built a prominent career by working with esteemed organizations such as the UAB Research Foundation and the University of Alabama Research Foundation. His work within these institutions has allowed him to pursue groundbreaking research and has contributed to his notable patent portfolio.

Collaborations

Collaboration has played a crucial role in Kappes' endeavors. He has worked alongside skilled colleagues such as Xiaoyun Wu and Zhengrong Yang, enhancing the depth and breadth of his research projects. These partnerships have fostered an environment of innovation and creativity that drives scientific discovery.

Conclusion

In summary, John Christopher Kappes stands out as a prominent inventor whose work in biotechnology and genetic therapies significantly impacts the field. With eight patents to his name and a history of collaboration with leading institutions and fellow researchers, Kappes continues to push the boundaries of scientific innovation. His dedicated contributions to the understanding and treatment of genetic conditions mark him as a key figure in modern scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…